Assessment of Annexin A2 as A Marker for Diagnosis of Hepatocellular Carcinoma in Compensated and Decompensated Hepatitis C Virus Treated Patients

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma

Serum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis

Serum amyloid A level as a marker of hepatocellular carcinoma in HCV-induced liver cirrhosis

Assessment of Cancer Antigen 125 in Post-HCV Chronic Liver Disease and Hepatocellular Carcinoma Patients

Serum Lactadherin as a Diagnostic Biomarker in Hepatitis C Virus Cirrhotic Patients with and without Hepatocellular Carcinoma

Study of Interleukin-18 in Chronic hepatitis C virus related liver diseases

Assessment of the Level of Soluble CD25 as a Marker for the Detection of Hepatocellular Carcinoma in Chronic Hepatitis C virus (HCV) Infected Patients

Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels